Endoscopy 2005; 37(12): 1174-1180
DOI: 10.1055/s-2005-921045
Original Article
© Georg Thieme Verlag KG Stuttgart · New York

Capsule Endoscopy in Gastrointestinal Lymphomas

D.  Flieger1 , R.  Keller1 , A.  May2 , C.  Ell2 , W.  Fischbach1
  • 1Dept. of Internal Medicine II, Aschaffenburg Hospital, Aschaffenburg, Germany
  • 2Dept. of Internal Medicine II, HSK Wiesbaden, Wiesbaden, Germany
Further Information

Publication History

Submitted 2 November 2004

Accepted after revision 19 April 2005

Publication Date:
05 December 2005 (online)

Background and Study Aims: Capsule endoscopy (CE) is a new procedure for small-bowel imaging. The potential contribution of this method to the diagnosis and staging of gastrointestinal lymphomas has not yet been evaluated. The aim of this prospective study was to assess the frequency and morphology of different forms of intestinal pathology in patients with gastrointestinal lymphomas.
Patients and Methods: Commercially available capsule video endoscopes were administered to 27 patients (16 men and 11 women, aged 27 - 77) with known gastrointestinal lymphomas. CE was also carried out in 30 control individuals.
Results: All seven patients with primary intestinal lymphomas who were examined were found to have pathological findings on CE - four with ulcerations, four with nodes, three with villous atrophy, and one with plaques/white villi. One patient with severe diarrhea was examined three times before and after chemotherapy, and improvement of the lesions was evident, as well as resolution of diarrhea. Twenty patients with gastric lymphoma were examined (16 with low-grade and four with high-grade B cell lymphomas). The capsule did not leave the stomach in three patients, suggesting impaired motility. The small-bowel transit times were 261 ± 41 min for intestinal lymphoma, 245 ± 62 min for gastric lymphoma, and 224 ± 82 min for controls (P > 0.05). Five of the 20 patients with gastric lymphoma had pathological findings in the intestine - three with plaques/white villi, two with nodes, and two with villous atrophy. In two patients, subsequent biopsies revealed secondary follicular lymphoma and high-grade lymphoma, respectively.
Conclusions: CE is a valuable diagnostic tool for defining the extent of bowel involvement and assessing the efficacy of treatment in patients with gastrointestinal lymphoma.

References

  • 1 Iddan G, Meron G, Glukhovsky A. et al . Wireless capsule endoscopy.  Nature. 2000;  405 417
  • 2 Costamagna G, Shah S K, Riccioni M E. et al . A prospective trial comparing small bowel radiographs and video capsule endoscopy for suspected small bowel disease.  Gastroenterology. 2002;  123 999-1005
  • 3 Ell C, Remke S, May A. et al . The first prospective controlled trial comparing wireless capsule endoscopy with push enteroscopy in chronic gastrointestinal bleeding.  Endoscopy. 2002;  34 685-689
  • 4 Fireman Z, Mahajna E, Broide E. et al . Diagnosing small bowel Crohn’s disease with wireless capsule endoscopy.  Gut. 2003;  52 390-392
  • 5 Herrerias J M, Caunedo A, Rodriguez-Tellez M. et al . Capsule endoscopy in patients with suspected Crohn’s disease and negative endoscopy.  Endoscopy. 2003;  35 564-568
  • 6 Jaffe E S, Banks P M, Nathwani B. et al . Recommendations for the reporting of lymphoid neoplasms: a report from the Association of Directors of Anatomic and Surgical Pathology. The Ad Hoc Committee on reporting of lymphoid neoplasms.  Hum Pathol. 2002;  33 1064-1068
  • 7 Scapa E, Jacob H, Lewkowicz S. et al . Initial experience of wireless-capsule endoscopy for evaluating occult gastrointestinal bleeding and suspected small bowel pathology.  Am J Gastroenterol. 2002;  97 2776-2779
  • 8 Williamson R C, Welch C E, Malt R A. Adenocarcinoma and lymphoma of the small intestine: distribution and etiologic associations.  Ann Surg. 1983;  197 172-178
  • 9 North J H, Pack M S. Malignant tumors of the small intestine: a review of 144 cases.  Am Surg. 2000;  66 46-51
  • 10 Fischbach W, Goebeler-Kolve M E, Dragosics B. et al . Long term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication therapy: experience from a large prospective series.  Gut. 2004;  53 34-37
  • 11 Fischbach W, Dragosics B, Kolve-Goebeler M E. et al . Primary gastric B-cell lymphoma: results of a prospective multicenter study. The German-Austrian Gastrointestinal Lymphoma Study Group.  Gastroenterology. 2000;  119 1191-1202
  • 12 Cogliatti S B, Schmid U, Schumacher U. et al . Primary B-cell gastric lymphoma: a clinicopathological study of 145 patients.  Gastroenterology. 1991;  101 1159-1170
  • 13 Radaszkiewicz T, Dragosics B, Bauer P. Gastrointestinal malignant lymphomas of the mucosa-associated lymphoid tissue: factors relevant to prognosis.  Gastroenterology. 1992;  102 1628-1638
  • 14 Fischbach W, Goebeler-Kolve M E, Greiner A. Diagnostic accuracy of EUS in the local staging of primary gastric lymphoma: results of a prospective, multicenter study comparing EUS with histopathologic stage.  Gastrointest Endosc. 2002;  56 696-700
  • 15 Koch P, del Valle F, Berdel W E. et al . Primary gastrointestinal non-Hodgkin’s lymphoma, 1: anatomic and histologic distribution, clinical features, and survival data of 371 patients registered in the German Multicenter Study GIT NHL 01/92.  J Clin Oncol. 2001;  19 3861-3873
  • 16 Rösch T, Ell C. Position paper on capsule endoscopy for the diagnosis of small bowel disorders.  Z Gastroenterol. 2004;  42 247-259
  • 17 Tang S J, Zanati S, Dubcenco E. et al . Capsule endoscopy regional transit abnormality: a sign of underlying small bowel pathology.  Gastrointest Endosc. 2003;  58 598-602
  • 18 May A, Nachbar L, Wardak A. et al . Double-balloon enteroscopy: preliminary experience in patients with obscure gastrointestinal bleeding or chronic abdominal pain.  Endoscopy. 2003;  35 985-991
  • 19 Carey E J, Heigh R I, Fleischer D E. Endoscopic capsule endoscope delivery for patients with dysphagia, anatomical abnormalities, or gastroparesis.  Gastrointest Endosc. 2004;  59 423-426

D. Flieger, M. D.

Medizinische Klinik II

Klinikum Aschaffenburg · Am Hasenkopf 1 · 63739 Aschaffenburg · Germany

Fax: +49-6021-32-3031

Email: dimitri.flieger@klinikum-aschaffenburg.de

    >